Overview
RKDA market data
Price History
RKDA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.71 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.57 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.59 – $6.71 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $1.4 · P/B 0.66 · P/S 0.29.
Company News
8-K filing — Arcadia Biosciences, Inc. (RKDA)SEC EDGAR · Jul 2, 2026, 8:21 PM
Arcadia Biosciences Files Prospectus Pursuant To Which Selling Stockholders May Offer Up To 11.92M Shares Of Common Stock For ResaleBenzinga · Jun 26, 2026, 8:45 PM
Arcadia Biosciences Q1 EPS $(2.11) Misses $(0.80) Estimate, Sales $1.100M Miss $1.600M EstimateBenzinga · May 14, 2026, 8:53 PM